4O Liquid biopsy-guided selection for anti-EGFR re-treatment in RAS/BRAF wild-type (wt) chemorefractory metastatic colorectal cancer patients (mCRC pts): Results from the phase II randomized PARERE trial. - Ciracì, P.; Germani, M.M.; Pietrantonio, F.; Lonardi, S.; Busico, A.; Chiaramonte, A.; Ricagno, G.; Esposto, R.; Formica, V.; Scartozzi, M.; Burgio, V.; Di Donato, S.; et al. (Annals of Oncology, 2025)